Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR+20.7%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+20.7%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 18.87% |
| 2023 | -52.24% |
| 2022 | -36.61% |
| 2021 | -11.48% |
| 2020 | -1.46% |
| 2019 | 7.37% |
| 2018 | 11.46% |
| 2017 | -0.24% |
| 2016 | -8.12% |
| 2015 | -10.45% |